By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DelMar Pharmaceuticals 

999 West Broadway
Suite 720
  British Columbia  V5Z 1K5  Canada
Phone: 1-604-629-5989 Fax:



Company News
DelMar Pharma Announces Upcoming Scientific Conference Presentations 10/13/2016 9:33:49 AM
DelMar Pharma Presents Data Supporting The Potential Of VAL-083 As A New Treatment For Ovarian Cancer At The 11th Biennial Ovarian Cancer Research Symposium 9/13/2016 8:54:49 AM
DelMar Pharma And Accurexa To Collaborate In The Development Of A Novel Combination Chemotherapy For The Local Treatment Of Brain Cancer 9/7/2016 9:02:25 AM
DelMar Pharma To Present At The 18th Annual Rodman & Renshaw Global Investment Conference On September 13, 2016 8/30/2016 11:28:33 AM
DelMar Pharma To Present At The 11th Biennial Ovarian Cancer Research Symposium 8/11/2016 11:29:49 AM
DelMar Pharma Announces Presentation At The European Association Of Neuro-Oncology (EANO) Annual Meeting In October 2016 7/21/2016 7:53:53 AM
DelMar Pharma To Ring The Nasdaq Stock Market Opening Bell On July 14 7/13/2016 8:21:07 AM
DelMar Pharma Announces Approval For Listing On NASDAQ 7/11/2016 7:21:25 AM
ASCO2016: DelMar Pharma Presents Phase I/II GBM Clinical Trial Data And Outlines Future Clinical Development Plans At ASCO 2016 Annual Meeting 6/6/2016 11:33:31 AM
DelMar Pharma Announces Successful Completion Of End-Of-Phase 2 Meeting With FDA On VAL-083 For The Treatment Of Refractory Glioblastoma Multiforme 5/25/2016 6:30:59 AM